Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Cell & Bioscience|May 17, 2014
Deficiency in steroid receptor coactivator 3 enhances cytokine production in IgE-stimulated mast cells and passive systemic anaphylaxis in miceXiaochun Xia, Wei Wan, Qiang Chen, et al.
The Journal of Biological Chemistry|January 12, 2021
Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expressionYuan Deng, Ming Li, Minghui Zhuo, et al.
Gastroenterology|November 26, 2018
Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in MiceKesong Peng, Lele Kou, Li Yu, et al.
Biomolecules|May 4, 2026
Histone Demethylase JMJD2D Suppresses Influenza A Virus Infection by Promoting RIG-I ExpressionXiaochun Xia, Jiadi Liang, Hanshi Guo, et al.
Frontiers in Pharmacology|February 21, 2022
Traditional Chinese Medicine Pien-Tze-Huang Inhibits Colorectal Cancer Growth and Immune Evasion by Reducing β-catenin Transcriptional Activity and PD-L1 ExpressionQiang Chen, Yilin Hong, Shihe Weng, et al.
Inflammation|January 5, 2021
Steroid Receptor Coactivator-3 Is Required for Inhibition of the Intestinal Muscularis Inflammatory Response of Postoperative Ileus in MiceKang Zou, Wenbo Chen, Jun Dai, et al.
Drug Design, Development and Therapy|April 14, 2025
Knowledge Mapping and Global Research Trends of Ginseng Polysaccharides: a Bibliometric Analysis with Visualizations from 1985 to 2023Pingli Mo, Bowen Gao, Rui Wang, et al.
Plos Pathogens|June 21, 2024
Histone demethylase JMJD2D protects against enteric bacterial infection via up-regulating colonic IL-17F to induce β-defensin expressionYong Zhang, Bei Li, Yilin Hong, et al.
Frontiers in Pharmacology|November 29, 2023
Chemical characterization and metabolic profiling of Xiao-Er-An-Shen Decoction by UPLC-QTOF/MSRuipei Yang, Lifang Wei, Jie Wang, et al.
Oncotarget|April 23, 2016
Downregulation of amplified in breast cancer 1 contributes to the anti-tumor effects of sorafenib on human hepatocellular carcinomaMing Li, Wei Wang, Yuzhen Dan, et al.
Pageof 4